CytoDyn Inc (OTCPK:CYDY)
$ 0.1351 -0.00065 (-0.48%) Market Cap: 143.01 Mil Enterprise Value: 172.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter Transcript

Jan 23, 2020 / NTS GMT
Release Date Price: $1.08 (-0.92%)
Jack Marks
Wall Street Reporter - Moderator

Good afternoon, everybody, and welcome to Wall Street Reporter's Next Super Stock conference for January 23, 2020. Today, we have a special presentation by Dr. Nader Pourhassan of CytoDyn, stock symbol is CYDY.

As most of you know, CytoDyn has a blockbuster potential portfolio of really exciting drugs in the pipeline for cancer, HIV. They just signed an $87.5 million licensing deal and CytoDyn has been a regular presenter at our events and those of you have been following us have probably noticed the stock going from $0.35 last time Dr. Pourhassan was here in November to recent the trade of I think [$1.11] this morning. Looks like this could be just the beginning.

So, for those of you who are new to Wall Street Reporter, the premise of the Next Super Stock conference is simple. We're looking for companies with big upside potential going after billion-dollar opportunities. Most importantly, right now they're positioned at key inflection points with really transformative growth potential ahead. And most importantly, they have CEOs and management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot